Interactomics-based analysis suggests that rhinitis and rhinitis with asthma are mechanistically different diseases

SAN DIEGO — As­traZeneca’s ex­per­i­men­tal PARP1 in­hibitor helped shrink tu­mors in near­ly half of peo­ple with breast can­cers har­bor­ing cer­tain DNA re­pair de­fects in an

The FDA said it worked with phar­ma com­pa­nies to pre­vent more than 200 drug short­ages last year. How­ev­er, the reg­u­la­tor still grap­pled with a steady